Skip to main content
HRES 280 117th Congress House Foreign Trade and International Finance Administrative law and regulatory procedures Asia China Competition and antitrust Competitiveness, trade promotion, trade deficits Department of Health and Human Services Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA) Free trade and trade barriers Government information and archives Health technology, devices, supplies Manufacturing Prescription drugs Trade agreements and negotiations

Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States…

Show full title

Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.

Introduced: March 26, 2021 Introduced by: Jackson, Ronny Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
This resolution expired with the 117th Congress
It was not agreed to before the 117th Congress (2021–2022) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Agreed to (House)
Mar 29, 2021
Referred to the Subcommittee on Health.
Mar 26, 2021
Referred to the Committee on Ways and Means, and in addition to the Committees on Foreign Affairs, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 26, 2021
Referred to the Subcommittee on Trade.
Mar 26, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This resolution commits to the use of competitive free market and free trade policies to combat national security threats caused by China and its attacks on the U.S. pharmaceutical manufacturing base.

The resolution urges the United States to (1) remove tax, regulatory, and debt burdens and barriers that have weakened this base; (2) empower the U.S. Trade Representative to take specified actions to counter harmful and unfair trade practices by China; (3) address shortcomings in Food and Drug Administration data collection related to foreign-sourced pharmaceutical ingredients; and (4) identify and streamline regulatory hurdles that have impeded the U.S. pharmaceutical manufacturing base.

What's happening now March 29, 2021

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 14
All 14 Republican 12
R
Spartz, Victoria
Indiana · Jun 8, 2021
 R
Carter, John R.
Texas · Apr 13, 2021
 R
Rutherford, John H.
Florida · Apr 13, 2021
 R
Harshbarger, Diana
Tennessee · Apr 1, 2021
 R
Baird, James R.
Indiana · Mar 26, 2021
 R
Banks, Jim
Indiana · Mar 26, 2021
 R
Franklin, Scott
Florida · Mar 26, 2021
Herrell, Yvette
· Mar 26, 2021
Hice, Jody
· Mar 26, 2021
 R
Mast, Brian J.
Florida · Mar 26, 2021
 R
McClintock, Tom
California · Mar 26, 2021
 R
Roy, Chip
Texas · Mar 26, 2021
 R
Salazar, Maria Elvira
Florida · Mar 26, 2021
 R
Tenney, Claudia
New York · Mar 26, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H. Res. 280: Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.. 117th Congress. Open America. https://openamerica.io/bill/117-HRES-280/
MLA
"H. Res. 280: Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HRES-280/.
Bluebook (legal)
H. Res. 280, 117th Cong. (2026), https://openamerica.io/bill/117-HRES-280/.
Markdown link
[H. Res. 280: Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.](https://openamerica.io/bill/117-HRES-280/)
Report a problem